Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant987 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,216 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00950144 | Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer | completed | — | 123 | City of Hope Medical CenterOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00779688 | A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers | completed | — | 130 | Mauna Kea TechnologiesINDUSTRY |
| 3 |
| Feb 10, 2011 |
| clinicaltrials |
| NCT01278381 | Prognostic Score To Predict Major Complications After Pancreaticoduodenectomy | completed | — | 700 | Università Vita-Salute San RaffaeleOTHER | 1 | Jan 17, 2011 | clinicaltrials |
| NCT00005594 | ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | 4 | University of Alabama at BirminghamOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT01248663 | Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery | completed | N/A | 64 | Medical University of ViennaOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00242190 | Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 40 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00192712 | Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 20 | Rambam Health Care CampusOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00902733 | Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer | completed | N/A | 125 | City of Hope Medical CenterOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00192842 | Gemcitabine With Curcumin for Pancreatic Cancer | completed | Phase 2 | 17 | Rambam Health Care CampusOTHER | 0 | Sep 22, 2010 | clinicaltrials |
| NCT00873353 | Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients(XELTA) | completed | Phase 2 | 32 | Grupo Gallego de Investigaciones OncologicasOTHER | 1 | Aug 18, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00294840 | Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment | completed | — | 70 | Rambam Health Care CampusOTHER | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00233415 | Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 100 | Stanford UniversityOTHER | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00761241 | Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT | completed | Phase 2 | 40 | Benaroya Research InstituteOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00303927 | Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene | completed | Phase 2 | 65 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 2 | Mar 19, 2010 | clinicaltrials |
| NCT00352131 | Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors | completed | Phase 1 | 50 | ImmunoGen, Inc.INDUSTRY | 1 | Mar 17, 2010 | clinicaltrials |
| NCT00316420 | Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer | completed | Phase 1 | 20 | Swedish Medical CenterOTHER | 1 | Mar 8, 2010 | clinicaltrials |
| NCT01059097 | Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy | completed | N/A | 610 | Università Vita-Salute San RaffaeleOTHER | 1 | Jan 29, 2010 | clinicaltrials |
| NCT00628186 | Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy | completed | N/A | 100 | Wakayama Medical UniversityOTHER | 1 | Jan 18, 2010 | clinicaltrials |
| NCT00744640 | Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma(GEMOXEL) | completed | Phase 1 / Phase 2 | 46 | University Hospital, Basel, SwitzerlandOTHER | 1 | Jan 12, 2010 | clinicaltrials |
| NCT01033695 | Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes | completed | — | 74 | Odense University HospitalOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00125021 | Tarceva and Capecitabine for Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00137761 | Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00990535 | High Dose Somatostatin Analogues in Neuroendocrine Tumors(HIDONET) | completed | Phase 2 | 28 | Federico II UniversityOTHER | 1 | Oct 7, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00220649 | Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | completed | Phase 1 | 25 | St. Luke's-Roosevelt Hospital CenterOTHER | 1 | Aug 17, 2009 | clinicaltrials |
| NCT00495924 | Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma | completed | — | 100 | KU LeuvenOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00644254 | The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma(ECLNI DPAC) | completed | — | 145 | KU LeuvenOTHER | 1 | Jul 7, 2009 | clinicaltrials |
| NCT00919282 | Gemcitabine (GFF) in Patients With Pancreatic Cancer(GFF) | completed | Phase 2 | 78 | CONKO-StudiengruppeOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00919659 | Parenteral Nutrition Support for Patients With Pancreatic Cancer | completed | Phase 2 | 32 | CONKO-StudiengruppeOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00385177 | Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors | completed | Phase 1 | 61 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00288925 | Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment | completed | Phase 1 / Phase 2 | 30 | Zeria PharmaceuticalINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00099294 | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer | completed | Phase 3 | 300 | Threshold PharmaceuticalsINDUSTRY | 11 | Apr 30, 2009 | clinicaltrials |
| NCT00102752 | Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer | completed | Phase 1 / Phase 2 | 47 | Threshold PharmaceuticalsINDUSTRY | 2 | Apr 30, 2009 | clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00102700 | ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | completed | Phase 2 | 66 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00234416 | IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 45 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00622622 | Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer | completed | Phase 1 | 21 | Wakayama Medical UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00252889 | Doxil Topotecan Doublet Cancer Study | completed | Phase 1 | 20 | Christiana Care Health ServicesOTHER | 1 | Jan 27, 2009 | clinicaltrials |
| NCT00377936 | EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas | completed | Phase 2 | 212 | MediGeneINDUSTRY | 3 | Nov 14, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00222469 | Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | University of OklahomaOTHER | 1 | Jul 9, 2008 | clinicaltrials |
| NCT00511264 | Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract | completed | — | 250 | Odense University HospitalOTHER | 1 | May 29, 2008 | clinicaltrials |
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | completed | Phase 2 | 5 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 6, 2008 | clinicaltrials |
| NCT00261092 | GEMOX: Oxaliplatin in Pancreatic Cancer | completed | Phase 2 | 48 | SanofiINDUSTRY | 1 | Apr 15, 2008 | clinicaltrials |
| NCT00657995 | Tight Glycemic Control by Artificial Pancreas | completed | N/A | 32 | Kochi UniversityOTHER | 1 | Apr 14, 2008 | clinicaltrials |
| NCT00644618 | Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy | completed | Phase 3 | 120 | Huazhong University of Science and TechnologyOTHER | 0 | Mar 27, 2008 | clinicaltrials |
Data updated 23 days agoSource updated Mar 2, 2011source: clinicaltrials